Reaction

Tachyarrhythmia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,467 reports · 99 co-occurring drugs

As of the last recalculation, Tachyarrhythmia appears in 2,467 FAERS reports alongside 99 co-occurring drug terms. The strongest observed disproportionality signal is DUTASTERIDE (PRR 52.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dutasteride	50	52.9	53.3
Indapamide	59	28.4	28.5
Amiodarone Hydrochloride	37	28.3	28.4
Moxifloxacin Hydrochloride	53	22.5	22.6
Torsemide	73	19.1	19.2
Theophylline	20	14.8	14.8
Bisoprolol Fumarate	208	14.0	14.0
Digoxin	114	14.0	14.0
Eplerenone	21	13.9	14.0
Azithromycin	64	13.7	13.8
Theophylline Anhydrous	20	13.7	13.7
Bupivacaine	15	13.6	13.6
Azithromycin Monohydrate	64	13.3	13.3
Norepinephrine Bitartrate	22	13.0	13.0
Fluticasone Furoate And Vilanterol Trifenatate	49	11.7	11.7
Irbesartan	58	11.2	11.2
Azithromycin Dihydrate	75	11.1	11.1
Propofol	47	11.0	11.1
Mometasone Furoate	53	10.9	11.0
Valsartan Oral	68	10.8	10.8
Dronedarone	13	10.8	10.8
Apixaban	83	10.8	10.8
Metoprolol Succinate Er Tablets	73	10.1	10.1
Dofetilide	12	9.7	9.7
Norepinephrine	12	9.5	9.5
Mesna Injection	9	9.2	9.2
Pantoprazole Sodium In 0.9% Sodium Chloride	66	9.2	9.2
Pantoprazole Sodium Injection	66	9.2	9.2
Ampicillin	9	9.2	9.2
Ampicillin Sodium	9	9.2	9.2
Mesna	9	9.0	9.1
Cefuroxime	12	8.9	8.9
Candesartan Cilexetil	27	8.7	8.8
Mepolizumab	50	8.6	8.7
Zonisamide	15	8.6	8.6
Meropenem	32	8.5	8.5
Doxyclycline Hyclate	17	8.5	8.5
Ramipril	119	8.5	8.5
Acetylcysteine	9	8.1	8.1
Magnesium Sulfate In Water For	12	8.0	8.0
Metoprolol Succinate	79	7.9	7.9
Rocuronium Bromide	11	7.9	7.9
Fluticasone Propionate And Salmeterol Xinafoate	55	7.9	7.9
Magnesium Sulfate Heptahydrate	12	7.8	7.8
Magnesium Sulfate	12	7.8	7.8
Amoxicillin And Clavulanate Potassium	24	7.5	7.5
Clopidogrel Bisulfate	86	7.3	7.3
Valsartan	88	7.3	7.3
Sevoflurane	7	7.1	7.1
Doxycycline Hyclate	54	6.9	6.9
Valsartan And Hydrochlorothiazide	11	6.9	6.9
Doxycycline	54	6.8	6.8
Diltiazem Hydrochloride Extended-Release Tablets	9	6.7	6.7
Doxazosin	22	6.7	6.7
Sodium Bicarbonate	18	6.6	6.6
Sodium Bicarbonate Injection,	18	6.6	6.6
Bendamustine Hcl	12	6.6	6.6
Sodium Chloride Tablet	56	6.5	6.6
Sodium Chloride Tablets	56	6.5	6.6
Sodium Chloride	60	6.5	6.5
Epoetin Alfa	9	6.4	6.4
Agalsidase Beta	7	6.4	6.4
Anti-Thymocyte Globulin (Rabbit)	6	6.3	6.3
Lactulose	28	6.2	6.2
Adrenalinum	30	6.2	6.2
Allopurinol	108	6.0	6.1
Sildenafil Powder,	25	6.0	6.0
Doxazosin Mesylate	25	5.9	5.9
Chlorthalidone	8	5.8	5.8
Metoprolol	162	5.7	5.7
Tiotropium Bromide	89	5.7	5.7
Metoprolol Tartrate Injection	121	5.6	5.6
Metoroprolol Tartrate	42	5.4	5.5
Letrozole	39	5.4	5.4
Nebivolol	10	5.3	5.3
Letrozole Tablets	30	5.3	5.3
Fentanyl	60	5.2	5.2
Sildenafil	35	5.2	5.2
Sofosbuvir	10	4.3	4.3
Linezolid	15	4.3	4.3
Cytarabine	30	4.3	4.3
Oseltamivir	4	4.2	4.2
Ibrutinib	40	4.2	4.2
Oxaliplatin	34	3.9	3.9
Dabigatran Etexilate	35	3.8	3.8
Cisplatin	33	3.6	3.6
Pemetrexed	9	3.6	3.6
Cetuximab	13	3.5	3.5
Tolvaptan	6	3.5	3.5
Doxorubicin	36	3.4	3.4
Gemcitabine	16	3.4	3.4
Bosentan	20	3.4	3.4
Darbepoetin Alfa	21	3.3	3.3
Gemcitabine Hydrochloride	20	3.2	3.2
Dabigatran Etexilate Mesylate	27	3.2	3.2
Paricalcitol	5	3.0	3.0
Alteplase	5	2.8	2.8
Ranibizumab	8	2.5	2.5
Pegfilgrastim	17	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.